Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study

被引：6
|
作者：
Ngyen, Liem Binh Luong [1 ]
Bauer, Rebecca [2 ]
Lesieur, Zineb [3 ]
Galtier, Florence [4 ]
Duval, Xavier [5 ]
Vanhems, Philippe [6 ]
Laine, Fabrice [7 ]
Tattevin, Pierre [8 ,9 ]
Durier, Christine [2 ]
Launay, Odile [1 ,3 ]
机构：
[1] Hop Cochin, AP HP, INSERM, CIC 1417, Paris, France
[2] INSERM, US19, Villejuif, France
[3] F CRIN I REIVAC, INSERM, Paris, France
[4] CHU Montpellier, St Eloi Hosp, INSERM, CIC 1411, Montpellier, France
[5] Hop Bichat Claude Bernard, AP HP, INSERM, CIC 1425, Paris, France
[6] Hosp Civils Lyon, Serv Hyg Epidemiol Infectiovigilance & Prevent, Lyon, France
[7] CHU Rennes, Inserm CIC 1414, Rennes, France
[8] CHU Rennes, Hop Pontchaillou, Serv Malad Infect, Rennes, France
[9] CHU Rennes, Hop Pontchaillou, Serv Reanimat Med, Rennes, France
来源：
INFECTIOUS DISEASES NOW | 2022年 / 52卷 / 01期
关键词：
Alpha variant; COVID-19; France; Vaccine; Vaccine effectiveness;
D O I：
10.1016/j.idnow.2021.12.002
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Background: Measuring vaccine effectiveness (VE) using real-life data is critical to confirm the effectiveness of licensed vaccine, which could strengthen vaccination adherence. Methods: We measured VE against adult COVID-19 hospitalization in five hospitals in France using a test negative design. We compared the odds of vaccinated patients hospitalized with COVID-19 with the odds of vaccinated patients hospitalized for the same symptoms with a negative test. Results: A total of 853 patients (463 cases and 390 controls) were included, with a total of 170 patients vaccinated (104 with one dose, 65 with two doses, and one with three doses). There were four cases of breakthrough infections, all in immunocompromised patients. The VE was 84.0% (CI0.95 = [72.6; 90.6]) for one dose and 96.2% (CI0.95 = [86.8; 98.9]) for two doses. Conclusion: Our results confirm the high VE of COVID-19 vaccine in France to prevent hospitalizations due to the alpha variant.
引用
收藏
页码：40 / 43
页数：4
相关论文
共 50 条
  • [1] Vaccine effectiveness against COVID-19: A test negative case-control study in Tunisia, August 2021
    Mziou, Emna
    Hchaichi, Aicha
    Letaief, Hejer
    Dhaouadi, Sonia
    Safer, Mouna
    Talmoudi, Khouloud
    Mhadhbi, Rim
    Elmili, Nawel
    Bouabid, Leila
    Derouiche, Sondes
    Bougatef, Souha
    Bellali, Hedia
    Ben Alaya, Nissaf Bouafif Ep
    VACCINE, 2024, 42 (07) : 1738 - 1744
  • [2] Evaluation of the COVID-19 vaccine effectiveness on the outcomes of COVID 19 disease in Iran: a test-negative case-control study
    Shadmani, Fatemeh Khosravi
    Moradi, Ghobad
    Naghipour, Mohammadreza
    Asadi, Fatemeh Torkaman
    Ahmadi, Ali
    Mirahmadizadeh, Alireza
    Haghdoost, Ali Akbar
    Mesgarpour, Bita
    Zahraei, Seyed Mohsen
    Goya, Mohammad Mehdi
    Mokhtari, Majid
    Safari-Faramani, Roya
    Zare, Fariba Zomorrodi
    Chegeni, Maryam
    Najafi, Farid
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test-negative case-control study
    Heidarzadeh, Abtin
    Moridani, Mohammadreza Amini
    Khoshmanesh, Saman
    Kazemi, Samira
    Hajiaghabozorgi, Marziyeh
    Karami, Manoochehr
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 128 : 212 - 222
  • [4] Vaccine effectiveness against mild and severe covid-19 in pregnant individuals and their infants in England: test negative case-control study
    Kirsebom, Freja C. M.
    Andrews, Nick
    Mensah, Anna A.
    Stowe, Julia
    Ladhani, Shamez
    Ramsay, Mary
    Bernal, Jamie Lopez
    Campbell, Helen Julia
    BMJ MEDICINE, 2024, 3 (01):
  • [5] Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
    Tamada, Yudai
    Takeuchi, Kenji
    Kusama, Taro
    Maeda, Megumi
    Murata, Fumiko
    Osaka, Ken
    Fukuda, Haruhisa
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [6] Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
    Yudai Tamada
    Kenji Takeuchi
    Taro Kusama
    Megumi Maeda
    Fumiko Murata
    Ken Osaka
    Haruhisa Fukuda
    BMC Infectious Diseases, 24
  • [7] Effectiveness of Covishield vaccine in preventing Covid-19-A test-negative case-control study
    Pramod, Stuti
    Govindan, Dhanajayan
    Ramasubramani, Premkumar
    Kar, Sitanshu Sekhar
    Aggarwal, Rakesh
    VACCINE, 2022, 40 (24) : 3294 - 3297
  • [8] COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain
    Mazagatos, Clara
    Delgado-Sanz, Concepcion
    Monge, Susana
    Pozo, Francisco
    Oliva, Jesus
    Sandonis, Virginia
    Gandarillas, Ana
    Quinones-Rubio, Carmen
    Ruiz-Sopena, Cristina
    Gallardo-Garcia, Virtudes
    Basile, Luca
    Barranco-Boada, Maria Isabel
    Hidalgo-Pardo, Olga
    Vazquez-Cancela, Olalla
    Garcia-Vazquez, Miriam
    Fernandez-Sierra, Amelia
    Milagro-Beamonte, Ana
    Ordobas, Maria
    Martinez-Ochoa, Eva
    Fernandez-Arribas, Socorro
    Lorusso, Nicola
    Martinez, Ana
    Garcia-Fulgueiras, Ana
    Sastre-Palou, Bartolome
    Losada-Castillo, Isabel
    Martinez-Cuenca, Silvia
    Rodriguez-del Aguila, Mar
    Latorre, Miriam
    Larrauri, Amparo
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (06) : 1014 - 1025
  • [9] Population-Level Effectiveness of an Inactivated Whole-Virion COVID-19 Vaccine: A Test Negative Case-Control Study in the Dominican Republic
    Perez-Then, Eddy
    Miric, Marija
    Qian, Han-Zhu
    Chen, Ying Qing
    Wang, Yixin
    Vallejo, Virginia
    Quezada, Wanda
    Flaquer, Melissa
    Olivo, Juan
    Castillo, Jean
    Garcia, Natalia
    Calderon, Katherine
    Cueto, Scarlet
    Veras, Bienvenido
    Russo, Miguel
    Jimenez, Indira
    Guzman, Sorileydi
    Garabito, Luz
    Cueto, Evelyn
    Colombo, Fatima
    Taveras, Dominga
    Torres, Dania
    Baez, Jeannette
    Yunen, Jose
    Koenig, Ellen
    Perez, Eladio
    Lopez, Oscar
    Medina, Fior Estephanie Severino
    Wang, Xuanyi
    Shao, Yiming
    Vermund, Sten H.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (03):
  • [10] Use of Recently Vaccinated Individuals to Detect Bias in Test-Negative Case-Control Studies of COVID-19 Vaccine Effectiveness
    Hitchings, Matt D. T.
    Lewnard, Joseph A.
    Dean, Natalie E.
    Ko, Albert I.
    Ranzani, Otavio T.
    Andrews, Jason R.
    Cummings, Derek A. T.
    EPIDEMIOLOGY, 2022, 33 (04) : 450 - 456
12345